Objective To study clinical features of respiratory distress syndrome (RDS) in neonates of different gestational ages (GA). Methods According to GA, 133 neonates with RDS were classified into GA <34 weeks group (n=66), GA 34-36 weeks group (late preterm neonates; n=31), and GA ≥37 weeks group (full-term neonates; n=36). The mothers' medical history during pregnancy and the condition of the neonates at birth were retrospectively analyzed, and the clinical data were compared between groups. Results Prenatal corticosteroids supplementation in the GA <34 weeks group was more common than that in the GA 34-36 weeks group (P < 0.05). Compared with the GA ≥37 weeks group and the GA 34-36 weeks group, the GA <34 weeks group showed a significantly lower rate of primary diseases, a significantly later time of the development of dyspnea (P < 0.05), and a higher rate of intraventricular hemorrhage (P < 0.05). Serum albumin levels in the GA <34 weeks group were significantly lower than in the GA ≥37 weeks group (P < 0.05). The GA ≥37 weeks group and the GA 34-36 weeks group showed a significantly higher reuse rate of pulmonary surfactant (P < 0.05). Use of high-frequency oscillatory ventilation was more common in the GA ≥37 weeks group compared with the GA <34 weeks group (P < 0.05). Conclusions The clinical features of RDS are different across neonates of different GA, suggesting that the pathogenesis of RDS may be different in neonates of different GA.
Key words
Respiratory distress syndrome /
Clinical feature /
Gestational age /
Neonate
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Rook M, Vargas J, Caughey A, et al. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort[J]. PLoS One, 2012, 7(3): e28343.
[2] Altman M, Vanpée M, Cnattingius S, et al. Risk factors for acute respiratory morbidity in moderately preterm infants[J]. Paediatr Perinat Epidemiol, 2013, 27(2): 172-181.
[3] Edwards MO, Kotecha SJ, Kotecha S. Respiratory distress of the term newborn infant[J]. Paediatr Respir Rev, 2013, 14(1): 29-36.
[4] Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update[J]. Neonatology, 2013, 103(4): 353-368.
[5] 刘敬. 足月新生儿呼吸窘迫综合征的诊断与治疗[J]. 中华实 用儿科临床杂志, 2013, 28(14): 1117-1120.
[6] Liu J, Yang N, Liu Y. High-risk Factors of Respiratory Distress Syndrome in Term Neonates: A Retrospective Case-control Study[J]. Balkan Med J, 2014, 31(1): 64-68.
[7] Speer CP. Neonatal respiratory distress syndrome: an inflammatory disease?[J]. Neonatology, 2011, 99(4): 316-319.
[8] 杨晓路, 郭俊良. 足月新生儿肺透明膜病临床病理分析[J]. 临床儿科杂志, 2000, 18(6): 361-363.
[9] Sun H, Xu F, Xiong H, et al. Characteristics of respiratory distress syndrome in infants of different gestational ages[J]. Lung, 2013, 191(4): 425-433.
[10] Holme N, Chetcuti P. The pathophysiology of respiratory distress syndrome in neonates[J]. Paediatrics and Child Health, 2012, 22(12): 507-512.
[11] Morris I, McCallion N, El-Khuffash A, et al. Serum albumin and mortality in very low birth weight infants[J]. Arch Dis Child Fetal Neonatal Ed, 2008, 93(4): F310-F312.
[12] Wang L, Chen L, Li R, et al. Efficacy of surfactant at different gestational ages for infants with respiratory distress syndrome[J]. Int J Clin Exp Med, 2015, 8(8): 13783-13789.
PDF(1300 KB)
